Abstract
The fate of Huntingdon Life Sciences (HLS) – the UK drugs-testing firm forced to the brink of closure by animal rights activists – still appears in danger as protestors promise to step up their action against the company and its financial backers. In the past year, several financial institutions have withdrawn their support from HLS after being targeted by campaigners intent on closing down the company. HLS came close to collapse in January, when the Royal Bank of Scotland called in its loan to the company, but a last-minute deal with Stephens, a US bank, provided funds that could secure its future for at least 12 months. Stop Huntingdon Animal Cruelty, the group leading the fierce campaign against HLS, has said that it will extend its protests to the firmcustomers, including major pharmaceutical companies. It has also pledged to take its campaign to the US, where it plans to link up with the US-based In Defense of Animals to put pressure on HLS's new financiers. Many are calling for the British government to do more to protect those involved in animal experiments from the aggressive tactics of some protestors. RC
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
